Skip to main content
. 2024 Oct 23;66(5):ezae379. doi: 10.1093/ejcts/ezae379

Table 4:

Details of the procedures for both Simultaneous and Staged group

Overall-44, N (%) Simultaneous group
Staged group
Overall-25, N (%) EVAR first-18, N (%) TAVI first-7, N (%) Overall-19, N (%) EVAR first-10, N (%) TAVI first–9, N (%)
Preoperative factors
 Male 30 (68) 13 (52) 7 (39) 5 (71) 17 (89) 9 (90) 8 (89)
 Urgent aneurysm 3 (7) 0 (0) 0 (0) 0 (0) 3 (16) 3 (30) 0 (0)
 Hostile bilateral femoral/iliac access 11 (25) 5 (20) 4 (22) 1 (14) 6 (32) 3 (30) 3 (33)
 TEVAR 8 (57) 3 (12) 3 (17) 0 (0) 5 (26) 2 (20) 3 (33)
 EVAR 36 (43) 22 (88) 15 (83) 7 (100) 14 (74) 8 (80) 6 (67)
 Days between procedures (Staged group) 72 (IQR: 57–87) 82 (IQR: 32–86) 65 (IQR: 28–88)
Intraoperative details
 General Anaesthesia TEVAR/EVAR 23 (52) 14 (56) 13 (72) 1 (14) 9 (47) 3 (30) 6 (67)
 Percutaneous femoral access TEVAR/EVAR 27 (61) 16 (64) 10 (56) 6 (86) 11 (58) 4 (40) 7 (78)
 Percutaneous femoral access TAVI 30 (68) 16 (64) 10 (56) 6 (86) 14 (74) 7 (70) 7 (78)
 Need for iliac adjunctive procedures 4 (9) 1 (4) 0 (0) 1 (14) 3 (16) 2 (20) 1 (11)
 Technical Success 44 (100) 25 (100) 18 (100) 7 (100) 19 (100) 10 (100) 9 (100)
Postoperative results
 Cardiac adverse events 2 (5) 0 (0) 0 (0) 0 (0) 2 (11) 1 (10) 1 (11)
 Cerebrovascular adverse events 2 (5) 1 (4) 0 (0) 1 (14) 1 (5) 0 (0) 1 (11)
 Respiratory adverse events 5 (11) 0 (0) 0 (0) 0 (0) 5 (26) 2 (20) 3 (33)
 Reinterventions 1 (2) 0 (0) 0 (0) 0 (0) 1 (5) 1 (10) 0 (0)
 Vascular access complication 2 (5) 1 (4) 1 (6) 0 (0) 1 (5) 0 (0) 1 (11)
 Death 1 (2) 0 (0) 0 (0) 0 (0) 1 (5) 1 (10) 0 (0)

EVAR: endovascular aortic repair; IQR: interquartile range; N: numbers; TAVI: transcatheter aortic valve implantation; TEVAR: thoracic endovascular aortic repair.